SCHEMBL2327015

SCHEMBL2327015

COc1ccccc1C(=O)N(c1cccc2ccccc12)[C@@H](CCS)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 3/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
LTC4S Q16873 1/20 0.36
FABP7 O15540 1/20 0.36
FABP3 P05413 1/20 0.36
FABP5 Q01469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2326949 0.91 L3MBTL1 (0.41) L3MBTL1NPC1MEN1KMT2AALDH1A1
SCHEMBL2327176 0.91 CACNA1B (0.40) L3MBTL1NPC1MEN1KMT2AALDH1A1
SCHEMBL2330882 0.84 CACNA1B (0.41) L3MBTL1NPC1MEN1KMT2AALDH1A1
SCHEMBL2331989 0.83 NPC1 (0.44) L3MBTL1NPC1KMT2AALDH1A1POLB
SCHEMBL2330835 0.83 CTNNB1 (0.42) NPC1MEN1KMT2AALDH1A1HPGD
SCHEMBL2331281 0.83 CHRNB2 (0.42) L3MBTL1MEN1KMT2AALDH1A1HTT
SCHEMBL2330797 0.78 CHRNB2 (0.41) L3MBTL1MEN1KMT2AALDH1A1HTT
SCHEMBL2329489 0.75 KMT2A (0.39) L3MBTL1MEN1KMT2AALDH1A1HPGD
SCHEMBL2332451 0.74 NPC1 (0.45) L3MBTL1NPC1KMT2AALDH1A1HPGD
SCHEMBL2329525 0.73 CHRNB2 (0.44) L3MBTL1MEN1KMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 L3MBTL1 1901/4885NPC1 4142/4885MEN1 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.